BC
MIST icon

Boxer Capital’s Milestone Pharmaceuticals MIST Stock Holding History

Boxer Capital’s Portfolio MIST Stock Details MIST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-309,007
Closed -$470K – 29
2024
Q3 		$470K Hold
309,007
– – 0.02% 65
2024
Q2 		$408K Hold
309,007
– – 0.02% 58
2024
Q1 		$553K Hold
309,007
– – 0.03% 56
2023
Q4 		$516K Hold
309,007
– – 0.03% 47
2023
Q3 		$958K Sell
309,007
-389,854
-56% -$1.21M 0.05% 65
2023
Q2 		$1.99M Hold
698,861
– – 0.09% 67
2023
Q1 		$2.75M Hold
698,861
– – 0.14% 62
2022
Q4 		$2.77M Hold
698,861
– – 0.15% 55
2022
Q3 		$6.42M Sell
698,861
-1,540,000
-69% -$11.7M 0.36% 47
2022
Q2 		$13.8M Hold
2,238,861
– – 0.87% 40
2022
Q1 		$14.4M Hold
2,238,861
– – 0.74% 38
2021
Q4 		$14.7M Sell
2,238,861
-333,333
-13% -$2M 0.57% 39
2021
Q3 		$14.7M Hold
2,572,194
– – 0.51% 52
2021
Q2 		$14.1M Hold
2,572,194
– – 0.5% 58
2021
Q1 		$14.9M Buy
2,572,194
+95,000
+4% +$695K 0.51% 53
2020
Q4 		$16.6M Buy
2,477,194
+700,000
+39% +$4.69M 0.53% 48
2020
Q3 		$13M Buy
1,777,194
+675,000
+61% +$4.84M 0.45% 49
2020
Q2 		$4.17M Hold
1,102,194
– – 0.18% 60
2020
Q1 		$2.03M Hold
1,102,194
– – 0.14% 59
2019
Q4 		$17.6M Hold
1,102,194
– – 1% 29
2019
Q3 		$20.6M Hold
1,102,194
– – 1.49% 20
2019
Q2 		$29.9M Buy
+1,102,194
New +$22.7M 2.57% 12

Other funds holding MIST

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AFA
Alta Fundamental Advisers New York $265M AUM 98.61% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return

Boxer Capital's MIST Position: Q4 2024 in Review

Boxer Capital sold out of Milestone Pharmaceuticals (MIST) in Q4 2024, closing a stake of 309,007 shares — an estimated $470K sold.

Boxer Capital first reported a position in MIST in Q2 2019 and held it in 22 quarters. The position peaked at $29.9M in Q2 2019. 47 funds tracked by Wall St. Rank hold MIST as of Q4 2024.

  • Boxer Capital reported no remaining Milestone Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
  • Boxer Capital sold 309,007 Milestone Pharmaceuticals shares in Q4 2024, an estimated $470K.
  • Boxer Capital first reported a position in Milestone Pharmaceuticals in Q2 2019 and held it in 22 quarters.
  • Boxer Capital's Milestone Pharmaceuticals position peaked at $29.9M in Q2 2019.
  • 47 funds tracked by Wall St. Rank held Milestone Pharmaceuticals as of Q4 2024.

Based on Boxer Capital's 13F filing for Q4 2024.